During the past decade, Cleveland Clinic Foundation conducted 573 clinical trials. In the 10-year time frame, 573 clinical trials started and 473 clinical trials were completed, i.e. on average, 82.5% percent of trials that started reached the finish line to date. In the past 5 years, 242 clinical trials started and 232 clinical trials were completed. i.e. 95.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Foundation" #1 sponsor was "National Cancer Institute (NCI)" with 199 trials, followed by "The Cleveland Clinic" with 108 trials sponsored, "Children's Oncology Group" with 85 trials sponsored, "Abbott Medical Devices" with 58 trials sponsored and "Boston Scientific Corporation" with 58 trials sponsored. Other sponsors include 825 different institutions and companies that sponsored additional 362 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 231 trials as a collaborator, "NRG Oncology" with 67 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 45 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 16 trials as a collaborator and "The Cleveland Clinic" with 15 trials as a collaborator. Other collaborators include 490 different institutions and companies that were collaborators in the rest 278 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Foundation" are "Heart Failure" (32 trials), "Recurrent Ovarian Carcinoma" (24 trials), "Recurrent Fallopian Tube Carcinoma" (20 trials), "Atrial Fibrillation" (19 trials) and "Recurrent Primary Peritoneal Carcinoma" (19 trials). Many other conditions were trialed in "Cleveland Clinic Foundation" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Foundation" are "Drug" (774 trials), "Other" (350 trials), "Device" (256 trials), "Biological" (217 trials) and "Procedure" (195 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (165 trials), "Placebo" (117 trials), "Quality-of-Life Assessment" (83 trials), "Carboplatin" (60 trials) and "Cyclophosphamide" (60 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Foundation" are 1158 trials for "All" genders, 120 trials for "Female" genders and 35 trials for "Male" genders.

Currently, there are 476 active trials in "Cleveland Clinic Foundation". 3 are not yet recruiting, 204 are recruiting, 265 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 659 completed trials in Cleveland Clinic Foundation, 13 suspended trials, and 124 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Foundation, 106 "Phase 1" clinical trials were conducted, 411 "Phase 2" clinical trials and 430 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 230 trials that are defined as “Not Applicable".